Stay updated on ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC

Sign up to get notified when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.
Latest website image capture
Clouds background image

Latest updates to the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record now displays details of the completed eribulin mesylate and pembrolizumab trial for metastatic triple-negative breast cancer, including eligibility criteria, study design, outcomes, locations, and study documents.
    Difference
    63%
    Check dated 2026-11-08T13:30:18.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T14:38:31.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide notice announces that federal agencies are transitioning from using “Artificial Intelligence” to “Super Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-25T15:29:00.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision identifier advances from v3.7.1 to v3.7.2 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T16:15:01.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision identifier updates from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T16:12:19.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating restricted access to the record. The visible page chrome and footer remain, but the study information cannot be loaded.
    Difference
    19%
    Check dated 2026-09-20T19:45:22.000Z thumbnail image

Stay in the know with updates to ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC

Enter your email address, and we'll notify you when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.